UBS Group’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $443K | Sell |
46,268
-18
| -0% | -$172 | ﹤0.01% | 4935 |
|
|
2025
Q1 | $430K | Sell |
46,286
-1,565
| -3% | -$14.6K | ﹤0.01% | 4778 |
|
|
2024
Q4 | $665K | Buy |
47,851
+36,887
| +336% | +$513K | ﹤0.01% | 4518 |
|
|
2024
Q3 | $258K | Buy |
10,964
+3,389
| +45% | +$79.7K | ﹤0.01% | 4525 |
|
|
2024
Q2 | $121K | Sell |
7,575
-6,597
| -47% | -$105K | ﹤0.01% | 4916 |
|
|
2024
Q1 | $232K | Buy |
14,172
+9,195
| +185% | +$151K | ﹤0.01% | 4608 |
|
|
2023
Q4 | $68.9K | Sell |
4,977
-333
| -6% | -$4.61K | ﹤0.01% | 5179 |
|
|
2023
Q3 | $73.1K | Sell |
5,310
-2,687
| -34% | -$37K | ﹤0.01% | 4928 |
|
|
2023
Q2 | $136K | Buy |
7,997
+3,378
| +73% | +$57.5K | ﹤0.01% | 4725 |
|
|
2023
Q1 | $74.2K | Buy |
4,619
+1,032
| +29% | +$16.6K | ﹤0.01% | 5076 |
|
|
2022
Q4 | $27.3K | Buy |
3,587
+3,496
| +3,842% | +$26.6K | ﹤0.01% | 6171 |
|
|
2022
Q3 | $1K | Buy |
+91
| New | +$1K | ﹤0.01% | 8937 |
|
|
2022
Q2 | – | Sell |
-1,740
| Closed | -$19K | – | 9753 |
|
|
2022
Q1 | $19K | Sell |
1,740
-3,733
| -68% | -$40.8K | ﹤0.01% | 6479 |
|
|
2021
Q4 | $77K | Buy |
+5,473
| New | +$77K | ﹤0.01% | 5450 |
|